IDELVION albutrepenonacog alfa 3500 IU powder (and diluent) for injection

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

Factor IX, Quantity: 3500 IU

Saatavilla:

CSL Behring Australia Pty Ltd

Lääkemuoto:

Solution

Koostumus:

Excipient Ingredients:

Antoreitti:

Intravenous

Kpl paketissa:

3500 IU

Prescription tyyppi:

Not scheduled. Not considered by committee

Käyttöaiheet:

IDELVION is indicated in all patients with haemophilia B for:,? Routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? Control and prevention of bleeding episodes,? Control and prevention of bleeding in the perioperative setting.

Tuoteyhteenveto:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store between 2 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Valtuutuksen tilan:

Registered

Valtuutus päivämäärä:

2020-11-19